Table 1.

Exosomes and Their Components as Biomarkers for Ovarian Cancer.

Biomarker	Trend	Type	Source	Recipient cells	Functions	Application	Ref
miR-21, miR-141, miR-200a, miR-200b, miR-200c, miR-203, miR-205, miR-214	Increase	miRNA	Cancer cells/serum	—	Biomarker	Early detection in serum	31
miR-21, miR-100, miR-200b, miR-320	Increase	miRNA	Cancer cells/plasma	Cancer cells	Biomarker	Early detection in plasma	32
miR-16, miR-93, miR-126, miR-223	Decrease	miRNA	Cancer cells/plasma	Cancer cells	Biomarker	Early detection in plasma	32
miR-192-5p, miR-1260a, miR-7977	Decrease	miRNA	Plasma	—	Biomarker	Early detection	33
miR-1290	Increase	miRNA	Cancer cells/serum	—	Biomarker	Early detection	34
miR-21-5p, miR-29a-3p, miR-30d-5p	Increase	miRNA	Clear cell carcinoma	—	Biomarker	Early detection	35
miR-200a, miR-200b, miR-200c, miR-1290	Increase	miRNA	Ascites	—	Biomarker	Early detection/prognosis	36
miR-484	Decrease	miRNA	Serum	—	Biomarker	Early detection in serum	37
miR-205	Increase	miRNA	Plasma	—	Biomarker	Prognosis	38
miR-4732-5p	Increase	miRNA	Plasma	—	Biomarker	Early detection in plasma	39
miR-320d, miR-4479, miR-6763-5p	Decrease	miRNA	Plasma		Biomarker	Early detection in plasma	40